Introduction
Oligodendroglioma - Overview
Oligodendroglioma - Therapeutics Development
Oligodendroglioma - Therapeutics Assessment
Oligodendroglioma - Companies Involved in Therapeutics Development
Oligodendroglioma - Drug Profiles
Oligodendroglioma - Dormant Projects
Oligodendroglioma - Discontinued Products
Appendix

List of Tables
Number of Products under Development for Oligodendroglioma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Oligodendroglioma - Pipeline by Agios Pharmaceuticals Inc, H2 2020
Oligodendroglioma - Pipeline by Alfasigma SpA, H2 2020
Oligodendroglioma - Pipeline by AngioChem Inc, H2 2020
Oligodendroglioma - Pipeline by Astellas Pharma Inc, H2 2020
Oligodendroglioma - Pipeline by Bayer AG, H2 2020
Oligodendroglioma - Pipeline by Boehringer Ingelheim International GmbH, H2 2020
Oligodendroglioma - Pipeline by Bristol-Myers Squibb Co, H2 2020
Oligodendroglioma - Pipeline by CDG Therapeutics Inc, H2 2020
Oligodendroglioma - Pipeline by Eli Lilly and Co, H2 2020
Oligodendroglioma - Pipeline by GtreeBNT Co Ltd, H2 2020
Oligodendroglioma - Dormant Projects, H2 2020
Oligodendroglioma - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Oligodendroglioma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• Agios Pharmaceuticals Inc
• Alfasigma SpA
• AngioChem Inc
• Astellas Pharma Inc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co
• CDG Therapeutics Inc
• Eli Lilly and Co
• GtreeBNT Co Ltd
• Immatics NV
• Ipsen SA
• Nascent Biotech Inc
• Northwest Biotherapeutics Inc
• Pfizer Inc
• Taiho Oncology Inc
• TheraBiologics Inc